NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Renwick MJ, Simpkin V, Mossialos E. Targeting innovation in antibiotic drug discovery and development: The need for a One Health – One Europe – One World Framework [Internet]. Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2016. (Health Policy Series, No. 45.)
Targeting innovation in antibiotic drug discovery and development: The need for a One Health – One Europe – One World Framework [Internet].
Show details- AB
Antibiotic
- ABSSSI
Acute bacterial skin and skin structure infection
- ACE
Antibiotic Conservation Effectiveness
- AHIF
Antibiotic Health Impact Fund
- AIDS
Acquired immune deficiency syndrome
- AIFM
Antibiotic Innovation Funding Mechanism
- AMC
Advanced market commitment
- AMR
Antimicrobial resistance
- AMRFF
Antimicrobial Resistance Funders Forum
- ANR
French National Research Agency
- ANTUK
Antibiotic Research UK
- ARLG
Antibacterial Resistance Leadership Group
- AVIESAN
French National Alliance for Life Sciences and Health
- BARDA
Biomedical Advanced Research and Development Authority
- BIO
Biotechnology Industry Organization
- BMBF
German Federal Ministry for Education and Research
- BSA
Broad spectrum antimicrobials
- BSAC
British Society of Antimicrobial Chemotherapy
- CABP
Community acquired bacterial pneumonia
- CDC
US Centers for Disease Control and Prevention
- cIAI
Complicated intraabdominal infection
- CIHR
Canadian Institutes of Health Research
- CIHR-III
Canadian Institutes of Health Research – Institute of Infection and Immunity
- COMBACTE
Combating Bacterial Resistance in Europe
- COMBACTE-CARE
Combating Bacterial Resistance in Europe – Carbapenem Resistance
- COMBACTE-MAGNET
Combating Bacterial Resistance in Europe – Molecules Against Gram-Negative Infections
- CTTI
Clinical Trials Transformation Initiative
- cUTI
Complicated urinary tract infection
- DFG
German Research Foundation
- DG RTD
Directorate-General for Research and Innovation
- DG SANTE
Directorate-General for Health and Food Safety
- DISARM
Developing an Innovative Strategy for Antimicrobial Resistance
- DNDi
Drugs for Neglected Diseases Initiative
- DZIF
German Centre for Infection Research
- EC
European Commission
- ECDC
European Centre for Disease Prevention and Control
- EDCTP
European and Developing Countries Clinical Trials Partnership
- EFPIA
European Federation of Pharmaceutical Industries and Associations
- EFSA
European Food Safety Authority
- EIB
European Investment Bank
- EMA
European Medicines Agency
- ENABLE
European Gram-Negative Antibacterial Engine
- EU
European Union
- FDA
US Food and Drug Administration
- FNIH
Foundation for National Institutes for Health
- FP6
Sixth Framework Programme
- FP7
Seventh Framework Programme
- GAIN
Generating Antibiotic Incentives Now
- GSK
GlaxoSmithKline
- GUARD
Global Union for Antibiotics Research and Development Initiative
- HAP
Hospital acquired pneumonia
- HIT
High intensity throughput
- HIV
Human immunodeficiency virus infection
- iABC
Inhaled Antibiotics in Bronchiectasis and Cystic Fibrosis
- IDSA
Infectious Disease Society of America
- IMI
Innovative Medicines Initiative
- IMMI
Inserm’s Institute for Microbiology and Infectious Diseases
- InnovFin ID
InnovFin Infectious Diseases
- Inserm
French National Institute of Health and Medical Research
- JPIAMR
Joint Programming Initiative on Antimicrobial Resistance
- LMIC
Low- and middle-income countries
- LPAD
Limited Population Antibacterial Drug
- NAA
Novel alternative to antibiotics
- ND4BB
New Drugs for Bad Bugs
- ND-AB
Neglected and disused antibiotics
- NGO
Non-governmental organization
- NIAID
National Institute for Allergies and Infectious Diseases
- NIH
US National Institutes for Health
- NPV
Net present value
- OECD
Organisation for Economic Co-operation and Development
- OHE
Office of Health Economics
- OMA
Options Market for Antibiotics
- PDP
Product development partnership
- PPP
Public-private partnership
- PQP
Prequalification of Medicines Program
- QIDP
Qualified Infectious Disease Product
- R&D
Research and development
- RCT
Randomized controlled trials
- ROI
Return on investment
- SME
Small and medium sized enterprises
- SRC
Swedish Research Council
- TATFAR
Transatlantic Task Force on Antimicrobial Resistance
- TB
Tuberculosis
- UK
United Kingdom
- UK-MRC
UK Medical Research Council
- UKCRC TIRI
UK Clinical Research Collaboration Translational Infection Research Initiative
- US
United States of America
- UN
United Nations
- WHO
World Health Organization
- ZonMw
Netherlands Organisation for Health Research and Development
- List of abbreviations - Targeting innovation in antibiotic drug discovery and de...List of abbreviations - Targeting innovation in antibiotic drug discovery and development
Your browsing activity is empty.
Activity recording is turned off.
See more...